In a unanimous decision on Thursday, the U.S. Supreme Court rejected a challenge to the widely-used abortion medication mifepristone, ruling to continue to allow the pills to be mailed to patients without an in-person doctor’s visit. The case had been introduced by anti-abortion organizations and right-wing doctors who had questioned the drug’s overall efficiency on dubious grounds.
BROADCASTING FOR INDEPENDENCE
